Maunjaro Price Comparison | Domestic Release Imminent? Summary of Differences from Wigobi

If you're looking for a diet pill, wouldn't you consider Maunja, the hottest name these days?

 

With the recent domestic release of the Maunjaro becoming increasingly popular, curiosity about its price is growing. Many are curious about the differences between the Wigobi and Maunjaro, and the extent of the price difference. Today, we'll provide a clear overview of these factors.

 

When will Maunja be released in Korea?

 

First of all, Maunjaro is already sold in the US, Japan, and Europe, and will soon be released in Korea.

To be precise, the 2.5mg and 5mg doses are scheduled to be released initially in prefilled pen form in mid-August 2025. Higher-dose products will be introduced sequentially thereafter.

 

It's highly likely that Korea Eli Lilly will sell the drug directly, and it hasn't been decided whether it will be jointly marketed with another pharmaceutical company, as with Wegobi. Price differences may arise depending on the distribution structure.

 

 

How much does a maunja cost?

 

The problem is the price. As of now, the domestic price for the mount has not been officially announced.

 

However, based on the overseas release price, the predictions are as follows:

• - Japan: Approximately 450,000 won (based on pre-filled pen)
• - USA: Approximately 730,000 won (per vial)
• - Europe: About 20-30% cheaper than Wigobi

 

Looking at this trend, the domestic release price is likely to be somewhat cheaper than the Wigobi.

Currently, the cost of Wegobi is approximately 400,000-600,000 won per month.

Therefore, it is highly likely that the monthly income will be around 350,000-500,000 won.

 

Additionally, pricing will be differentiated by capacity, so the higher the capacity, the higher the price.

 

What is the difference between Maunjaro and Wigobi?

 

In terms of effectiveness, there are many reviews that say that Maunjaro is more effective in weight loss than Wegobi.

Global clinical results show:

 

• - Maunjaro: Average weight loss of 22.8 kg over 72 weeks (20.2% weight loss rate)
• - Wegobi: Average weight loss of 15 kg over 72 weeks (weight loss rate of 13.7%)

 

With this level of difference, the perceived effect is likely to be significant.

 

 

The mechanism of action is also different.

 

• Wegobi is a GLP-1 agonist
• Maunzaro is a GLP-1 + GIP dual agonist
•  

Therefore, stronger appetite suppression and metabolism control effects are expected.

 

Summary of price comparisons for Maunjaro

 

To sum up, the price of the mount has not been disclosed yet.

 

• Possibly 10-20% lower than the Wigobi
• Estimated monthly income: 350,000 to 500,000 won
• Maunjaro has the advantage in weight loss effect

 

This is the flow.

 

With the release date approaching mid-August, pricing information is likely to be revealed soon.

 

We will update the domestic release price information as soon as it is released.
If you are interested, please bookmark it and keep an eye on it.

 

 

If you are considering diet pills,
Comparing the prices of Wegobi and Maunjaro is something you should definitely check.

If you want to get the best value for money, choosing Maunja might be a reasonable choice.